Lewy body disease and dementia. A review
- PMID: 8604954
Lewy body disease and dementia. A review
Abstract
Lewy bodies (LBs) are intracytoplasmic neuronal inclusions sometimes found in the brain stem, diencephalon, basal ganglia, and cerebral cortex. Cases designated as diffuse Lewy body disease (DLBD) demonstrate widespread cortical and subcortical Lewy body formation. The fact that DLBD is possibly the second most common cause of dementia after Alzheimer's disease is not generally recognized. We hope to emphasize the importance of this common neurodegenerative disorder by reviewing the literature and our own experience with DLBD. The English-language literature dealing with the clinical and pathological features of DLBD was reviewed. Pathological material from the Canadian Brain Tissue Bank, Toronto, Ontario, was reviewed over a 2-year period from 1991 through 1993. Prominent LB pathology may occur in isolation or mixed with pathological changes seen in Alzheimer's disease. Lewy body diseases include Parkinson's disease that presents with a classic movement disorder and sometimes dementia, and DLBD where LBs occur in a widespread distribution in the cortex in addition to the usual subcortical sites. Diffuse LB disease usually presents with a neurobehavioral syndrome that may include hallucinations, delusions, and psychosis; all patients eventually become demented. A day-to-day fluctuating mental state may be an important distinguishing clinical feature. Parkinsonism may follow the psychiatric disturbance although occasionally it is a presenting feature. Serious life- threatening side effects may occur with the use of standard neuroleptics. The variable clinical features and additional presence of Alzheimer-type pathological changes in many cases of DLBD has led to a confusing and inconsistent classification of LB disease and, together with little awareness of its existence, its misdiagnosis. Although DLBD may be the second most common cause of dementia, the terminology and classification of LB disorders and their relationship to Alzheimer's disease remain sources of intense debate. Further research is needed to resolve these issues and to provide insight into the pathogenesis of LB formation and accompanying neuronal degeneration.
Similar articles
-
[Diffuse Lewy body disease].Rinsho Shinkeigaku. 1997 Dec;37(12):1134-6. Rinsho Shinkeigaku. 1997. PMID: 9577669 Japanese.
-
Dementia and neuropathology in Lewy body disease.Adv Neurol. 1993;60:456-63. Adv Neurol. 1993. PMID: 8420170
-
[Dementia in diffuse Lewy body disease].Psychiatr Pol. 1995 May-Jun;29(3):307-17. Psychiatr Pol. 1995. PMID: 7652084 Polish.
-
Dementia with Lewy bodies.Semin Clin Neuropsychiatry. 2003 Jan;8(1):46-57. doi: 10.1053/scnp.2003.50006. Semin Clin Neuropsychiatry. 2003. PMID: 12567332 Review.
-
Making the diagnosis of mixed and non-Alzheimer's dementias.Arch Pathol Lab Med. 1995 Nov;119(11):1023-31. Arch Pathol Lab Med. 1995. PMID: 7487402 Review.
Cited by
-
Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.J Geriatr Psychiatry Neurol. 2001 Fall;14(3):145-66. doi: 10.1177/089198870101400308. J Geriatr Psychiatry Neurol. 2001. PMID: 11563438 Free PMC article. Review.
-
Antipsychotic medications and the elderly: effects on cognition and implications for use.Drugs Aging. 2001;18(1):45-61. doi: 10.2165/00002512-200118010-00004. Drugs Aging. 2001. PMID: 11232738 Review.
-
Comorbidity profile in dementia with Lewy bodies versus Alzheimer's disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry.Alzheimers Res Ther. 2014 Oct 6;6(5-8):65. doi: 10.1186/s13195-014-0065-2. eCollection 2014. Alzheimers Res Ther. 2014. PMID: 25478027 Free PMC article.
-
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2. Cochrane Database Syst Rev. 2021. PMID: 35608903 Free PMC article.
-
Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand.J Neurol Neurosurg Psychiatry. 2002 Aug;73(2):134-40. doi: 10.1136/jnnp.73.2.134. J Neurol Neurosurg Psychiatry. 2002. PMID: 12122169 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical